T\u00fcbin\u00adgen \u2014 SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment has recei\u00adved capi\u00adtal commit\u00adments of over EUR 220 million for its now sixth fund at first closing. Faster than expec\u00adted, the T\u00fcbin\u00adgen-based health\u00adcare inves\u00adtor has thus alre\u00adady excee\u00added its target of 200 million euros at the first closing of the subscrip\u00adtion. The sixth gene\u00adra\u00adtion of SHS funds also targets majo\u00adrity and mino\u00adrity invest\u00adments in the health\u00adcare indus\u00adtry. 12\u201315 enga\u00adge\u00adments are plan\u00adned. Inves\u00adtors can still parti\u00adci\u00adpate in SHS VI until the \u201cfinal closing\u201d.<\/p>\n
As part of the place\u00adment of the sixth gene\u00adra\u00adtion of funds, the inves\u00adtor base was further inter\u00adna\u00adtio\u00adna\u00adli\u00adzed. More than half of the SHS VI inves\u00adtors have alre\u00adady inves\u00adted in prede\u00adces\u00adsor funds, and some of them have signi\u00adfi\u00adcantly increased their subscrip\u00adtion to the new gene\u00adra\u00adtion of funds. SHS attri\u00adbu\u00adtes the strong demand to its unique selling propo\u00adsi\u00adtion as a sector specia\u00adlist and the successful tran\u00adsac\u00adtions of the last fund generations.<\/p>\n
\u201cWe would like to thank our inves\u00adtors for their trust,\u201d conti\u00adnues Huber\u00adtus Leon\u00adhardt <\/strong>(photo \u00a9 SHS), the SHS part\u00adner and mana\u00adging direc\u00adtor respon\u00adsi\u00adble for fund\u00adrai\u00adsing<\/strong>. \u201cWith our sixth gene\u00adra\u00adtion of funds, we are once again provi\u00adding access to private equity in the growing health\u00adcare market. In addi\u00adtion to fund perfor\u00admance, our sector exper\u00adtise and access to tran\u00adsac\u00adtions are key factors for our inves\u00adtors. In addi\u00adtion, our ESG and inves\u00adtor rela\u00adti\u00adons exper\u00adtise, as well as our range of co-invest\u00adment oppor\u00adtu\u00adni\u00adties, are also rele\u00advant to many of our clients. We are very plea\u00adsed that with fund gene\u00adra\u00adtion six we have been able to further inter\u00adna\u00adtio\u00adna\u00adlize our inves\u00adtor base and expand it to include very pres\u00adti\u00adgious addresses.\u201d<\/p>\n The more than 60 inves\u00adtors in the SHS VI Fund come from the fund of funds, insu\u00adrance compa\u00adnies, pension funds, foun\u00adda\u00adti\u00adons, family offices, banks, health\u00adcare groups, church inves\u00adtors and entre\u00adpre\u00adneurs. The largest inves\u00adtors include, for exam\u00adple, the Euro\u00adpean Invest\u00adment Fund, the Scan\u00addi\u00adna\u00advian foun\u00adda\u00adtion Reald\u00adania, the Swiss Hels\u00adana Healt\u00adhIn\u00advest, the Baden-W\u00fcrt\u00adtem\u00adberg-based L\u2011Bank and major family offices. Further\u00admore, the SHS invest\u00adment team itself has inves\u00adted significantly.<\/p>\n Focus on growth finan\u00adcing and corpo\u00adrate succession<\/strong><\/p>\n \u201cWe see in our deal flow a variety of fast-growing health\u00adcare compa\u00adnies, both young and estab\u00adlished, that are candi\u00adda\u00adtes for invest\u00adment by the new fund. Stric\u00adter regu\u00adla\u00adtion and a high need for inno\u00adva\u00adtion and inter\u00adna\u00adtio\u00adna\u00adliza\u00adtion are leading to incre\u00adasing capi\u00adtal requi\u00adre\u00adments in the indus\u00adtry. For other compa\u00adnies, it is a matter of a successful hando\u00adver to the next gene\u00adra\u00adtion. Here too, as an expe\u00adri\u00aden\u00adced part\u00adner, we can provide compa\u00adnies with targe\u00adted and compe\u00adtent support, both with mino\u00adrity and majo\u00adrity share\u00adhol\u00addings,\u201d says Uwe Stein\u00adba\u00adcher, Mana\u00adging Part\u00adner at SHS.<\/p>\n The fund focu\u00adses on corpo\u00adrate tran\u00adsac\u00adtions of up to EUR 250 million. The fund can refi\u00adnance the corre\u00adspon\u00adding equity tran\u00adches with up to EUR 50 million from its own resour\u00adces. In case of higher equity requi\u00adre\u00adments, SHS increa\u00adses the volu\u00admes by co-invest\u00adments of inves\u00adtors inves\u00adted in the fund or syndi\u00adca\u00adtes with friendly private equity houses. Expan\u00adsion and inno\u00adva\u00adtion finan\u00adcing, succes\u00adsion situa\u00adtions and share\u00adhol\u00adder chan\u00adges repre\u00adsent the focus of the invest\u00adments sought. Majo\u00adrity and mino\u00adrity share\u00adhol\u00addings are possible.<\/p>\n About SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment mbH<\/strong><\/p>\n \u201cSHS, an indus\u00adtry inves\u00adtor, is a private equity firm foun\u00added in 1993 that makes invest\u00adments in health\u00adcare compa\u00adnies in Europe. The focus of invest\u00adments is on expan\u00adsion finan\u00adcing, share\u00adhol\u00adder chan\u00adges and succes\u00adsion situa\u00adtions. \u201cBuil\u00adding Euro\u00adpean Health\u00adcare Cham\u00adpi\u00adons\u201d is the invest\u00adment philo\u00adso\u00adphy accor\u00adding to which SHS finan\u00adces and deve\u00adlops port\u00adfo\u00adlio compa\u00adnies. The T\u00fcbin\u00adgen-based inves\u00adtor is taking both mino\u00adrity and majo\u00adrity stakes. SHS funds\u2019 natio\u00adnal and inter\u00adna\u00adtio\u00adnal inves\u00adtors include pension funds, funds of funds, foun\u00adda\u00adti\u00adons, family offices, stra\u00adte\u00adgic inves\u00adtors, entre\u00adpre\u00adneurs and the SHS manage\u00adment team. The equity invest\u00adment of the AIFM-regis\u00adtered company is up to EUR 50 million. Volu\u00admes beyond this can be imple\u00admen\u00adted with a network of co-inves\u00adtors. When making invest\u00adment decis\u00adi\u00adons, SHS places strong empha\u00adsis on conside\u00adring ESG aspects and is ther\u00ade\u00adfore commit\u00adted to the UN PRI guide\u00adlines. SHS is curr\u00adently inves\u00adt\u00ading from its sixth fund, laun\u00adched in 2022, with a volume of more than EUR 200 million. www.shs-capital.eu<\/p>\n","protected":false},"excerpt":{"rendered":" T\u00fcbin\u00adgen \u2014 SHS Gesell\u00adschaft f\u00fcr Betei\u00adli\u00adgungs\u00adma\u00adnage\u00adment has recei\u00adved capi\u00adtal commit\u00adments of over EUR 220 million for its now sixth fund at first closing. Faster than expec\u00adted, the T\u00fcbin\u00ad\u00adgen-based health\u00adcare inves\u00adtor has thus alre\u00adady excee\u00added its target of 200 million euros at the first closing of the subscrip\u00adtion. The sixth gene\u00adra\u00adtion of SHS funds also targets [\u2026]<\/p>\n","protected":false},"author":2,"featured_media":45532,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1369,1373],"tags":[],"class_list":["post-45534","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-investors","category-venture-capital-en"],"yoast_head":"\n